Skip to content

Efficacy of a Sensory Comfort Room in Agitation Control

Evaluation of the Effectiveness of a Comfort-sensory Room in the Control of Agitation in a Functional Mental Health Rehabilitation Area

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06547671
Enrollment
62
Registered
2024-08-09
Start date
2021-05-01
Completion date
2023-05-01
Last updated
2024-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Disorders, Severe

Brief summary

In the initial approach of the study, it was considered that the comfort room would be used by all patients with GCT treated in the Functional Rehabilitation Area 1 (ARF 1) of the Álava Psychiatric Hospital. However, with the onset of the covid-19 pandemic, the service itself decided to separate the patients into two units, in order to reduce positive contacts. Consequently, the use of the comfort room will only be available for one of the two units, which will be considered as the intervention group, while the other unit will be considered as the control group. It is also important to note that the patients in the intervention group unit have a more severe mental state than those in the control group. The control group are older and more psychopathologically stable patients. So already from the initial moment of the study they are two populations with different characteristics. Main Objective: To determine the effectiveness of the use of a sensory comfort room in the functional rehabilitation area 1 of the HPA. It would be considered effective if mechanical restraints decrease by 5% in the intervention group with respect to the previous year.

Interventions

OTHEREmployment of a confort room to help in anxiety and agitation moments.

Use of the sensory comfort room located in the unit itself, decorated in soft and relaxing tones with motifs inspired by nature. It has relaxation sofas, rocking chair, aromatherapy, chromotherapy, projector, music of the user's choice, weighted blanket mats, balls of various sizes......... to teach people admitted to the area alternatives to cope and control anxiety and prevent the escalation of agitation, as well as to guide them in strategies to help them relax.

Sponsors

Bioaraba Health Research Institute
Lead SponsorNETWORK

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Not randomized clinical trial in parallel groups

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients admitted to functional rehabilitation area 1 presenting with questionable, mild or moderate Agitation (score less than or equal to 20 on the PEC scale) or at the patient's request. * To have freely accepted to participate in the intervention and to have signed the informed consent. An information sheet will also be given to the patient and an information sheet to the tutor (APPENDIXES 1 and 2). Experts in easy reading are consulted to adapt this document.

Exclusion criteria

* Severe and extremely severe agitation (score greater than or equal to 21 on the PEC scale). Immediate previous physical aggression. * Declination of the signature of informed consent. * Any participant who does not comply with the rules of use of the room will be excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
Number of mechanical restraintsUp to 24 monthsMechanical restraint is understood as the extreme therapeutic intervention, through the application of immobilizing restrictive devices to limit a patient's freedom and, in turn, allows us to ensure their own safety and/or that of other

Secondary

MeasureTime frameDescription
Change in the agitation levelThrough study completion, an average of 2 yearsAgitation Score in Positive and Negative Symptoms Scale, Excitement Component (PEC) It is a scale with five items: Tension; Uncooperativeness; Hostility; Poor impulse control; and Excitement. Each of these items is rated with the following scores: 1. Absent. 2. Minimal. 3. Mild. 4. Moderate. Moderately severe. 6. Severe. 7. Extreme. A higher score on the PEC scale indicates greater agitation. The classification of the level of agitation is as follows: Questionable (5-10 points), mild (11-15 points) Moderate (16-20 points) Moderately severe (20-25 points) Severe (26-30 points or Item impulse control \> 4) Extremely severe (30-35 points). Whether or not the score on the PEC scale is lower before using the room and afterwards will be evaluated (15). It is considered that there is a decrease in the PEC scale if it is lower by one point. Before room use and afterwards.
Number of isolationsUp to 24 monthsDefined as the supervised confinement of a patient in a locked room alone for a period of time to protect the patient, or staff, from serious harm
Number of patients who need Rescue medicationUp to 24 monthsRescue medication to overcome the crisis

Other

MeasureTime frameDescription
Cognitive level with mini-mental scale.At baselineThis is the most widely used brief cognitive test in Spain. It is mainly used to detect cognitive disorders associated with neurodegenerative diseases such as Alzheimer's disease. There are 2 versions of 30 and 35 points. The test has 5 items (orientation, fixation, concentration and calculation, memory, language and construction). Impairment is considered to be present when the score is less than 23 points
Patients satisfaction questionnaire with confort roomThrough study completion, an average of 2 yearsSatisfaction and Proposals for room improvement, completed after each use
DiagnosisAt baselineAccording to the International Classification of Diseases
Age of mental disease evolutionAt baselineNumerical variable
Professionals satisfaction questionaire with confort roomThrough study completion, an average of 2 yearsAbout their experience with the employment of room, completed after each use
AgeAt baselineNumerical variable
SexAt baselineMale, famale

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026